Free Republic

www.LibertyJuice.com This particular article disgusted and infuriated me. Dr. John Holdren, Obama’s Science Czar, told those gathered at an AAAS (American Association for the Advancement of Science) meeting that, “America can’t expect to be number one in everything indefinitely.” Then he went on to say that it wasn’t “purely bad that other countries were beginning to make gains on us.” This mindset comes straight out of Loserville and is an embarrassing representation of America’s unique qualities and principles that have consistently made us the most incredible nation in the world. We are historically a nation that knows no limits or...

LOS ANGELES (Reuters) - A high dose of Teva Pharmaceutical Industries Ltd.'s multiple sclerosis drug Copaxone is more effective at limiting relapses and brain lesions than the standard dose, without more side effects, researchers said on Wednesday. "For some people a higher dose may work better," said Dr. Jeffrey Cohen of the Cleveland Clinic's MS research center and lead investigator of a small nine-month trial comparing the two doses. The study, funded by Israel-based Teva, found that a 40 milligram injection of Copaxone reduced inflammatory disease activity 38 percent more than a 20 mg dose. Rates of side effects, mainly...

Multiple Sclerosis Drug Combined with Lipitor May Stop or Reverse Disease - Dosages Cut in Half with Fewer Negative Side Effects March 16th 2006 Lipitor Combining treatments may improve outcomes for patients with Multiple Sclerosis (MS), according to research done on mice and published online by the Journal of Clinical Investigation. Scott S. Zamvil and colleagues at the University of California, San Francisco found that mice treated with a combination of Glatiramer acetate (GA) and atorvastatin (Lipitor) demonstrated “a significant prevention and reversal of clinical MS severity” of MS symptoms.  Lipitor is a cholesterol lowering drug that has previously been...